AptarGroup Q1 Earnings Beat Estimates but Decline Y/Y, Shares Dip 1%

ATR tops Q1 earnings estimates on strong sales growth, but profit declines, pharma headwinds and margin pressure send shares down despite an upbeat Q2 outlook.